Category: Recent News

Last week CASAA CEO Alex Clark and Member Coordinator Kristin Noll-Marsh discuss what Brian King, the new Director of FDA’s Center for Tobacco Products, said (and DIDN’T say) about vaping during the Q&A he had on February 24, 2023 with Greg Conley and Allison Boughner of American Vapor Manufacturers. If you’d like to read a transcript of King’s conversation with AVM, click here.

From Brent Stafford at Regulator Watch

Harm reduction warrior shares frustration over public health’s strident refusal to consider nicotine vaping in the fight to end deadly forms of tobacco use.

*Guest: Fiona Patten, Leader of The Reason Party, M.P. for Northern Metropolitan Region, Legislative Council, Parliament of Victoria

Original Airdate: June 9, 2022

Posted: March 1, 2023

Make RegWatch happen, go to support(dot)regulatorwatch(dot)com

Watch GFN News every second Thursday at GFN.TV

Make RegWatch happen, go to: support.regulatorwatch.com

From Brent Stafford at Regulator Watch

Hysteria over vaping is not a by-product of public health’s war on vaping; it’s the intended result.

Public health seeks to generate fear and panic to impede logical thinking, from the so-called “epidemic” of teen vaping and “vaping-related lung illness” to the claim that nicotine harms developing brains.

In this special edition of RegWatch, Martin Cullip, International Fellow at the Taxpayers Protection Alliance and prolific writer on harm reduction policy, provides an intelligent reaction to a litany of panics public health has pushed concerning nicotine vaping products.

Only on RegWatch by RegulatorWatch.com.

Released: February 24, 2023
Produced by Brent Stafford

This episode is supported by DEMAND VAPE

Make RegWatch happen, go to: support.regulatorwatch.com

What we gonna do?

We’re gonna tell you all about TPE23.
We’re gonna discuss the Elf Bar situation.
We’re gonna have a chat(GPT) about vaping.
We’re gonna talk about the outrage over a photo.
We’re gonna get politically erect.
We’re gonna do SHOTS!!

“E-cigarettes (vapes) are currently the most popular aid used to quit smoking in England and are used by around 4.3 million adults in Great Britain, the majority of whom are ex-smokers. A recent Cochrane systematic review found that e-cigarettes are a more effective quitting aid for smokers than nicotine patches or gum.

A major independent review of the evidence on the health effects of vaping, commissioned by the Office for Health Improvement and Disparities, concluded that “vaping poses only a small fraction of the health risks of smoking and that smokers should be encouraged to use vaping products (or medicinally licensed products) for stopping smoking”.

E-cigarette use among 11-17 year olds who have never smoked remains low, with only 1.7% of never smokers vaping at least monthly. While we are seeing an increase in vaping among children and young adults, the vast majority are young people who’ve already tried smoking. Vaping among those who haven’t tried smoking has to date largely been experimental with people just trying it once or twice.

It is vital that health professionals are provided with accurate, evidence-based information on vaping so that they can deliver advice and support to smokers, children and families.”

ARTICLE LINK:  ‘There are many myths about e-cigarettes and vaping’

“Kenneth Warner, dean emeritus and the Avedis Donabedian Distinguished University Professor Emeritus at the University of Michigan’s School of Public Health, says there is enough evidence to support e-cigarettes’ use as a first-line aid for smoking cessation in adults. “Far too many adults who want to quit smoking are unable to do so,” Warner said. “E-cigarettes constitute the first new tool to help them in decades. Yet relatively few smokers and indeed health care professionals appreciate their potential value.” In a study published in Nature Medicine, Warner and colleagues took a global view of vaping, examining countries that promote vaping as a smoking cessation and countries that don’t. While agencies in the United States and Canada acknowledge the potential benefit of e-cigarette use, they deem the evidence to recommend e-cigarettes for smoking cessation as insufficient, according to the authors. However, in the United Kingdom and New Zealand there is high-level support and promotion of e-cigarettes as a first-line smoking cessation treatment option. “We believe that governments, medical professional groups and individual health care professionals in countries such as the U.S., Canada and Australia should give greater consideration to the potential of e-cigarettes for increasing smoking cessation,” Warner said. “E-cigarettes are not the magic bullet that will end the devastation wrought by cigarette smoking, but they can contribute to that lofty public health goal.””

ARTICLE LINK:  Researchers: Rethink e-cigarettes’ role in treating cigarette smokers’ nicotine addiction

JOIN US IN
Total Product Expo 2023

[TPE – Total Product Expo 2023] is scheduled for next week, which takes place from 22th – 24th February 2023 at the Las Vegas Convention Center | Las Vegas, NV. And we’ll be there at Booth #3211.

We are thrilled to announce that this year we’re featuring:
[INNOBAR Series] Creative products with biggest innovation breakthrough from AQUIOS LAB, with live demonstrations throughout the show. If you’re looking for the product with constant performance, you cannot miss this!

[KOL engaged] The beloved KOLs Dimi Agrafiotis and Phil Busardo will be gracing the INNOKIN booth with their presence and can’t wait to share all new technology with you!

[Spin to Win] You might even have a chance at scoring some pretty cool Innokin samples and souvenirs.

Don’t hesitate to reach out to sales@innokin.com to make an appointment with our team.
See you there!

Sincerely,
Innokin Team

“In a two-part Sensible Medicine post, Dr. Satel will argue that the use of electronic cigarettes should be welcomed as a disruptive public health innovation. Electronic cigarettes easily top the list of “disruptive technologies in public health.” In 2014, the Oxford English Dictionary christened “vape” the Word of the Year, a tribute to the impressive rise of the electronic cigarette, a battery-powered device that heats a flavored solution containing nicotine and converts it into an inhalable, or “vape-able,” aerosol. Electronic cigarettes have become the most important tool in the battle against cigarette smoking. And yet, today, instead of rejoicing at the promise of electronic cigarettes, health agencies have fueled a massive campaign of doubt regarding its health advantages to smokers. E-cigarettes are also more effective than nicotine-replacement aids. In the second part of this post I will discuss the (debunked) claim that vaping poses a “gateway” to smoking for teens, a brief history of the distrust of tobacco harm reduction, the lop-sided risk communication mischaracterizing teen vaping at the expense of informing adults accurately, how anxiety over teens has shaped the FDA’s heavy-handed regulatory approach, smarter approaches deployed in the UK, and how Big Tobacco wins when adult smokers are scared away from vaping.”

ARTICLE LINK:  Vaping: The Great Innovation Public Health Failed to Embrace

From Brent Stafford at Regulator Watch

Unity. It’s the long sought-for desire of many within vaping advocacy. No more backbiting and griping between groups over strategy and tactics in the fight to save vaping.

Only focused and efficient action.

The dream may finally be a reality with the recent announcement of a “strategic alignment” between two powerhouse vaping advocacy groups in the U.S., SFATA, the Smoke-Free Alternatives Trade Association, and the USVA, the United States Vaping Association.

Joining us today to walk through the “unified stance” of the two groups are SFATA president April Meyers and USVA president Travis Pinkerton. Also, Darryl Tempest joins the conversation as SFATA’s strategic advisor and representative from the North American Vapor Alliance.

Could unified forces make a difference?

Find out!

Only on RegWatch by RegulatorWatch.com

Released: February 14, 2023
Produced by Brent Stafford

Make RegWatch happen, go to: support.regulatorwatch.com